ORIC
Oric Pharmaceuticals Inc
13.30$
-1.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +2.3% | -0.8% | +4.2% | -0.7% | +12.6% | -0.7% | +2.6% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +9.3% | -10.3% | +31.8% | +7.8% | +2.5% | -22.9% | +24.0% | -5.8% | -10.1% | +21.6% | +15.5% | – | |
| – | +10.4% | +1.2% | +0.7% | +0.6% | +6.8% | +6.3% | +5.4% | -7.2% | +10.1% | -5.9% | +10.0% | – | |
| – | +8.7% | -7.8% | +25.4% | +6.4% | +2.5% | -16.7% | +19.4% | -6.1% | -6.7% | +15.7% | +13.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -90.3% | -224.9% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.